TN2011000206A1 - Compositions and methods of use soluble thrombomodulin variants - Google Patents
Compositions and methods of use soluble thrombomodulin variantsInfo
- Publication number
- TN2011000206A1 TN2011000206A1 TN2011000206A TN2011000206A TN2011000206A1 TN 2011000206 A1 TN2011000206 A1 TN 2011000206A1 TN 2011000206 A TN2011000206 A TN 2011000206A TN 2011000206 A TN2011000206 A TN 2011000206A TN 2011000206 A1 TN2011000206 A1 TN 2011000206A1
- Authority
- TN
- Tunisia
- Prior art keywords
- soluble thrombomodulin
- compositions
- methods
- variants
- thrombomodulin variants
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/366—Thrombomodulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/7455—Thrombomodulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11380108P | 2008-11-12 | 2008-11-12 | |
PCT/US2009/061407 WO2010056472A2 (fr) | 2008-11-12 | 2009-10-21 | Compositions et méthodes d'utilisation de variants de thrombomoduline |
Publications (1)
Publication Number | Publication Date |
---|---|
TN2011000206A1 true TN2011000206A1 (en) | 2012-12-17 |
Family
ID=42111790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TN2011000206A TN2011000206A1 (en) | 2008-11-12 | 2011-04-25 | Compositions and methods of use soluble thrombomodulin variants |
Country Status (21)
Country | Link |
---|---|
US (1) | US20110207670A1 (fr) |
EP (1) | EP2355839A2 (fr) |
JP (1) | JP2012508742A (fr) |
KR (1) | KR20110083665A (fr) |
CN (1) | CN102216326A (fr) |
AU (1) | AU2009314413A1 (fr) |
BR (1) | BRPI0922033A2 (fr) |
CA (1) | CA2743141A1 (fr) |
CL (1) | CL2011001065A1 (fr) |
CO (1) | CO6362021A2 (fr) |
CR (1) | CR20110239A (fr) |
DO (1) | DOP2011000133A (fr) |
EA (1) | EA201170679A1 (fr) |
EC (1) | ECSP11011049A (fr) |
IL (1) | IL212209A0 (fr) |
MA (1) | MA32775B1 (fr) |
MX (1) | MX2011005005A (fr) |
SV (1) | SV2011003904A (fr) |
TN (1) | TN2011000206A1 (fr) |
WO (1) | WO2010056472A2 (fr) |
ZA (1) | ZA201103179B (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014020183A1 (fr) * | 2012-08-03 | 2014-02-06 | Ici Immunochemical Intelligence Gmbh | Essai de diagnostic in vitro de troubles de l'hémostase |
WO2021126822A1 (fr) * | 2019-12-20 | 2021-06-24 | Blue Blood Biotech Corp. | Domaines fonctionnels de la thrombomoduline destinés à être utilisés pour favoriser les fonctions des ostéoblastes et la cicatrisation osseuse |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992000325A1 (fr) * | 1990-06-27 | 1992-01-09 | Mochida Pharmaceutical Co., Ltd. | Polypeptides anticoagulants |
CA2156255C (fr) * | 1993-12-17 | 2008-02-05 | Yasuyuki Kunihiro | Dispositif a semi-conducteur |
US5916874A (en) * | 1994-04-20 | 1999-06-29 | Asahi Kasei Kogyo Kabushiki Kaisha | Method for treating liver injury |
US5639625A (en) * | 1994-09-26 | 1997-06-17 | Oklahoma Medical Research Foundation | Method for detecting antibodies to thrombomodulin in patients |
EP1573005A2 (fr) * | 2002-12-02 | 2005-09-14 | Biovec LLC | Expression ex vivo et in vivo du gene de thrombomoduline pour traiter des maladies cardiovasculaires et des maladies vasculaires peripheriques |
WO2004076635A2 (fr) * | 2003-02-25 | 2004-09-10 | Biovec B.V. | Applications therapeutiques du gene de la thrombomoduline au moyen de vecteurs viraux et non viraux |
PL1948216T3 (pl) * | 2005-10-13 | 2011-10-31 | Lilly Co Eli | Leczenie ostrej niewydolności nerek za pomocą rozpuszczalnej trombomoduliny |
CA2665691A1 (fr) * | 2006-10-06 | 2008-04-17 | Asahi Kasei Pharma Corporation | Agent therapeutique et/ou ameliorant pour la coagulation intravasculaire disseminee |
CA2671863C (fr) * | 2006-12-12 | 2015-07-21 | Eli Lilly And Company | Procede de traitement de sujets atteints d'une insuffisance renale aigue au moyen de variantes de la thrombomoduline |
-
2009
- 2009-10-21 AU AU2009314413A patent/AU2009314413A1/en not_active Abandoned
- 2009-10-21 KR KR1020117010724A patent/KR20110083665A/ko not_active Application Discontinuation
- 2009-10-21 EP EP09740604A patent/EP2355839A2/fr not_active Withdrawn
- 2009-10-21 EA EA201170679A patent/EA201170679A1/ru unknown
- 2009-10-21 JP JP2011536368A patent/JP2012508742A/ja not_active Withdrawn
- 2009-10-21 BR BRPI0922033A patent/BRPI0922033A2/pt not_active Application Discontinuation
- 2009-10-21 MX MX2011005005A patent/MX2011005005A/es not_active Application Discontinuation
- 2009-10-21 US US13/126,474 patent/US20110207670A1/en not_active Abandoned
- 2009-10-21 CA CA2743141A patent/CA2743141A1/fr not_active Abandoned
- 2009-10-21 CN CN2009801451443A patent/CN102216326A/zh active Pending
- 2009-10-21 WO PCT/US2009/061407 patent/WO2010056472A2/fr active Application Filing
-
2011
- 2011-04-07 IL IL212209A patent/IL212209A0/en unknown
- 2011-04-25 TN TN2011000206A patent/TN2011000206A1/fr unknown
- 2011-04-29 ZA ZA2011/03179A patent/ZA201103179B/en unknown
- 2011-05-06 CR CR20110239A patent/CR20110239A/es not_active Application Discontinuation
- 2011-05-09 MA MA33821A patent/MA32775B1/fr unknown
- 2011-05-11 DO DO2011000133A patent/DOP2011000133A/es unknown
- 2011-05-11 CL CL2011001065A patent/CL2011001065A1/es unknown
- 2011-05-12 CO CO11058574A patent/CO6362021A2/es not_active Application Discontinuation
- 2011-05-12 SV SV2011003904A patent/SV2011003904A/es unknown
- 2011-05-12 EC EC2011011049A patent/ECSP11011049A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2012508742A (ja) | 2012-04-12 |
ECSP11011049A (es) | 2011-06-30 |
WO2010056472A3 (fr) | 2010-08-19 |
KR20110083665A (ko) | 2011-07-20 |
CO6362021A2 (es) | 2012-01-20 |
EP2355839A2 (fr) | 2011-08-17 |
AU2009314413A1 (en) | 2010-05-20 |
DOP2011000133A (es) | 2011-06-30 |
CA2743141A1 (fr) | 2010-05-20 |
US20110207670A1 (en) | 2011-08-25 |
CN102216326A (zh) | 2011-10-12 |
IL212209A0 (en) | 2011-06-30 |
BRPI0922033A2 (pt) | 2015-12-15 |
SV2011003904A (es) | 2011-07-06 |
MX2011005005A (es) | 2011-05-25 |
EA201170679A1 (ru) | 2012-04-30 |
CR20110239A (es) | 2011-06-09 |
WO2010056472A2 (fr) | 2010-05-20 |
CL2011001065A1 (es) | 2011-10-07 |
ZA201103179B (en) | 2012-10-31 |
MA32775B1 (fr) | 2011-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA106748C2 (uk) | Похідні проліну як інгібітори катепсину | |
MX2012004551A (es) | Nuevas composiciones para prevenir y/o tratar trastornos de almacenamiento lisosomal. | |
MY150602A (en) | Subtituted-quinoxaline-type piperidine compounds and the uses thereof | |
MY153948A (en) | Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof | |
MX370664B (es) | Inhibidores de la proteína regulada por glucosa 94 (gpr94) selectivos y usos de los mismos. | |
MX2011006725A (es) | Combinacion de inhibidores de aurora cinasa y anticuerpos anti-cd20. | |
MX2011011950A (es) | Composiciones de dexmedetomidina sublinguales y metodos de uso de las mismas. | |
TR201708567T4 (tr) | Sigma ligandların kemik kanseri ağrısında kullanımı. | |
EA201170753A1 (ru) | Налмефена гидрохлорид дигидрат | |
TW200700071A (en) | Novel use | |
IN2012DN02423A (fr) | ||
WO2007146983A3 (fr) | Compositions et procédés destinés au traitement de maladies | |
WO2008112647A3 (fr) | Radical nitroxyde en tant que traitement pour la neurodégénération | |
MX2014010940A (es) | El uso de antitrombina en el tratamiento de preeclampsia. | |
WO2007079312A3 (fr) | Compositions et procédés de traitement d’affections pathologiques médiées par l'actine | |
GB201316955D0 (en) | Composition comprising a diindolymethane and a retinoid to treat a skin condition | |
WO2010054328A3 (fr) | Compositions et méthodes pour l'inhibition de la formation et de la signalisation du complexe cripto/grp78 | |
MA32416B1 (fr) | 7-sulfanylmethyl-, 7-sulfinymethyl-et 7-sulfonylmethyl-indoles substitues et leur utilisation | |
TN2011000206A1 (en) | Compositions and methods of use soluble thrombomodulin variants | |
MX2011012538A (es) | Terapia de combinacion para el tratamiento del mieloma multiple. | |
SG178967A1 (en) | Antimicrobial compositions and products | |
UA44395U (ru) | Применение тиоцетама в качестве диуретического средства с мягким мочегонным действием в комплексном лечении | |
SI1948216T1 (sl) | Zdravljenje akutne ledviäśne odpovedi s topnim trombomodulinom | |
WO2010051129A3 (fr) | Nouveaux dérivés d'imidazolidinedione comme agents antimalariques, leur préparation, et procédés d'utilisation | |
WO2010138955A3 (fr) | Procédés et compositions pour traiter la néoplasie |